Sinead Keogh’s Post

A great evening attending the Jumar Bioincubator (Camille Shanahan) x What The Health (Emily Casey) event hearing about the CSL success story and what it might take for it to happen again in Australia. The graph is hard to see here, but shows absolutely aspirational growth across 100+ years, driven in part by a number of strategic acquisitions (and divestments). Many insights from speaker Andrea Douglas from CSL - but a few emphasis points were: 🔎🤔remember the core tech focus 👥 attract & harness people/partners with the skills to help you succeed 🌏 succeed globally, to succeed in Australia 🌐 expand into adjacent techs that complement your capabilities 📣 use your voice to advocate for changes that will benefit the industry as a whole, including yourself 📈 take calculated risks, and my personal favourite... 🙌 develop expertise and complex tech that is hard for competitors to replicate

I’m excited to be attending Bio-Europe from November 4-6 in Stockholm. Looking forward to reconnecting with our valued partners and exploring new opportunities for collaboration. Feel free to reach out if you’ll be there as well – I’d love to meet and discuss how we can work together! #BioEurope #Networking #BusinessDevelopment #Collaboration #Partnerships #LifeSciences #PharmaIndustry"

We are preparing for #EuroPLX84 Lisbon in Feb 2024. Excited to interact with thought leaders from the industry for collaborations on various fronts. #lisbon #healthcareinnovation #pharmaindustry #pharmabusiness #genericmedicines

As this year's JP Morgan healthcare week is behind us, the time has come for life science professionals to set their sights on next year's event. 🔍 Discover why attending JP Morgan should be a top priority for Swedish companies and learn from the experiences of Evelina Vågesjö from ILYA Pharma, Anne-Marie Wenthzel from Sprint Bioscience and SwedenBIOs Marjo Puumalainen who have attended JP Morgan in the past. 💡 Find out how SwedenBIO supports member companies during the bustling week, from discounted access to partnering conferences to invaluable meeting facilities. 📝 Read the article here: https://lnkd.in/dStdUjG2 #JPmorganHealthcareWeek #LifeScienceProfessionals #Networking #Partnerships #GlobalOpportunities #IndustryGrowth

Excited to be attending the Asembia conference this year! Looking forward to connecting with industry leaders, gaining insights into the latest trends, and exploring opportunities for collaboration. Let's connect if you're also here! #AsembiaConference #Weismarkets #specialtypharmacy

BIO-Europe® is celebrating a remarkable 30 years in 2024, and we want you to be a part of it! We are looking for innovative companies to present at our anniversary event. With over 50 spots available for onsite presentations, this is your chance to gain significant visibility and forge valuable connections. Apply before August 12th for your chance to be included in our special 30th-anniversary presentation line-up. What are the benefits of presenting? 👀 INCREASED VISIBILITY. Raise your company's profile and generate interest among top-tiers investors, biopharma execs and potential partners attending BIO-Europe. 📹 PRE-RECORD YOUR PITCH. All BIO-Europe presenters will have the opportunity to pre-record their pitch to be watched on demand for all registered attendees up to 3 weeks before the event. 🗓️ MORE MEETINGS. Your presentation in partneringONE® will include a link for attendees to schedule one-to-one meetings with your company. Statistics from previous events show that presenting companies receive up to 20% more meeting requests. View your presentation options>> http://spr.ly/6049e2I51 #BIOEurope #PresentingCompanies #Innovation #Stockholm #Partnering

 “While some are waiting for the IPO’s to come, there are a lot of interesting listed companies here today, you can invest in!”- Peter Legind-Hansen, Nasdaq The flagship indexes in the US are in all-time high and OMX Nordic is close to all time high despite a still little high interest rate and inflation. So, there IS a lot of money out there and the future and trends are looking brighter, yet there is still a lot of selectivity.  Already listed biotech and healthcare companies are more mature now and closer to reaching their ultimate goals but have much lower share prices than in 2021 due to the risk appetite and cost of capital. Two-day conference with Experts insights from international investors, successful dealmakers, Market Access experts – spiced with pitches from innovative Nordic biopharma companies – organized by BioStock - Connecting Innovation and Capital today and tomorrow. A conference connecting Nordic growth stage biopharma companies with global investors, expanding into new markets, creating global partnerships… We have a lot to offer and potential in the Nordic life science sector. Medicon Valley Alliance our mission is to strengthen our eco-system but also calling for increased collaboration within life science triple helix in the Nordics. Thank you to BioStock - Connecting Innovation and Capital for the invitation for these insightful days! HealthCap Agio Capital Sound Bioventures Sunstone Life Science Ventures Jonas Söderström

Ghana Legalizes Cannabis for Medical & Industrial Purposes Ghana’s Parliament voted to legalize cannabis for medical and industrial use with strict THC limits, aligning with a global trend and potentially unlocking significant economic and employment opportunities across the nation. Lawmakers in Ghana’s Parliament voted this month to legalize the cultivation of cannabis for medical and industrial purposes, according to Africa News.com. Under the December 14 decision, the country’s Interior Minister was given the authority to begin issuing cultivation licenses. Licenses are ultimately expected for every aspect of the cannabis industry including cultivation, distribution, processing, sale, import, and export, according to the report. #cannabis #cannabisindustry #cannabisnews #cannabismedicinal

𝗪𝗿𝗮𝗽𝗽𝗶𝗻𝗴 𝗨𝗽 𝗕𝗜𝗢-𝗘𝘂𝗿𝗼𝗽𝗲 𝗦𝗽𝗿𝗶𝗻𝗴 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗕𝗮𝗿𝗰𝗲𝗹𝗼𝗻𝗮 💼    As we bid farewell to BIO-Europe Spring 2024, let's take a moment to reflect on the lively atmosphere and collaborative spirit that filled the event's halls.    ✨ Facts & Figures ✨    🤝 ~120,000 meeting requests  🤝 ~20,000 meetings  🏢 1,947 companies represented  👥 3,452 delegates attended  💌 MONIPOL prepared ~280 meeting requests and had 25 meetings    These numbers speak volumes about the energy and collaboration present at the event. We were fortunate to connect with many companies interested in exploring our services: throughout the event, we made it a priority to prepare thoroughly and understand our potential clients' needs. This emphasis on research and client-centricity beforehand ensured that meetings were not only productive but also truly beneficial for everyone involved 🤝    𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐦𝐢𝐬𝐬𝐞𝐝 𝐭𝐡𝐞 𝐜𝐡𝐚𝐧𝐜𝐞 𝐭𝐨 𝐜𝐨𝐧𝐧𝐞𝐜𝐭 𝐰𝐢𝐭𝐡 𝐮𝐬 𝐚𝐭 𝐭𝐡𝐞 𝐞𝐯𝐞𝐧𝐭? Don't worry! Contact us for follow-ups and learn more about how we can support your trials. Let's continue the conversation and explore exciting opportunities at the Virtual Partnering Event, held on 26-27 March 📅     A big thank you to everyone who made BIO-Europe Spring 2024 such a success. We are looking forward to connecting further and supporting innovative biotech pioneers.    Another big thanks to EBD Group for providing a platform to connect the global BioPharma community. We are pleased to have played a part in fostering this vibrant atmosphere.      #BIOEuropeSpring #Biotech #CRO #clinicaltrials #clinicaldevelopment 

"At the heart of Europe, Benelux is like a drop of ink spreading its influence internationally; an in-depth study conducted by KBC Securities placed Belgium as Europe’s leading country for biotech in 2024." - Marjoke Le Roy for BioVox Jan Wauters, our Science and Technology Counselor from Flanders Investment & Trade (FIT), recently discussed Flanders’ pivotal role as a knowledge hub within the Benelux life sciences ecosystem. Here are some key insights from the interview: 👉 Leadership in Biotech: Belgium leads Europe in biotech, driven by Flanders' dynamic life sciences sector. 👉Government Support: Strong backing from the government, including financial aid and favorable tax systems, fosters innovation. 👉Collaborative Ecosystem: Continuous dialogue between industry, academia, and government is crucial. #FlandersLifeSciences #Innovation #GlobalOpportunities #Flanders Read the full article: https://lnkd.in/etHPYi3a